Due to health issues, this site is no longer maintained and will be shut down shortly.

KTTAW Pasithea Therapeutics Corp. - Warrant

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.  This security was issued by Pasithea Therapeutics Corp., whose common stock symbol is KTTA.

$0.04  -0.01 (-12.47%)
As of 03/21/2023 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Warrants
Category3:  Operating Companies
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  09/15/2021
Outstanding shares:  2,898,551
Average volume:  12,029
Market cap:   $12,571,086
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy